This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Centro De Inmunologia Molecular, Centro De Immunologia Molecular. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 24 
1 out of 8 Years Active: 1999-2002
Title: The Innovations of Irene Beausoleil Delgado
Introduction
Irene Beausoleil Delgado is a notable inventor based in Habana, Cuba, recognized for her significant contributions to the field of immunotherapy through her groundbreaking research and patents. With a total of three patents, her work primarily focuses on the development of anti-idiotypic monoclonal antibodies that play a crucial role in the fight against malignant tumors.
Latest Patents
Delgado’s latest patents include innovative therapeutic applications of anti-idiotypic monoclonal antibodies. These include compositions featuring the antibodies that are specifically designed to target N-glycolyl residues of gangliosides, which are commonly found on the surface of cancer cells. These monoclonal antibodies serve as immunomodulators, enhancing the body’s immune response against tumors. Notably, her inventions indicate a capacity to induce a strong anti-idiotypic response in xenogeneic models, demonstrating protective effects against malignant tumors in animal studies.
Career Highlights
Throughout her career, Irene Beausoleil Delgado has worked with esteemed institutions such as the Centro de Inmunología Molecular and the Centro De Inmunología Molecular. Her expertise in biotechnology and immunotherapy is reflected in her patents, which showcase her innovative approach to cancer treatment, paving the way for potential breakthroughs in how we understand and combat malignancies.
Collaborations
In her journey as an inventor, Delgado has collaborated with many professionals in the field, including notable coworkers Eladio Iglesis Guerra and Gumersinda Bombino Lopez. These collaborations contribute to a rich environment of shared knowledge and innovation, further enhancing the impact of her work on cancer research.
Conclusion
Irene Beausoleil Delgado exemplifies the spirit of innovation in the realm of immunotherapy, with her patents marking significant advancements in cancer treatment methodologies. Her contributions highlight the importance of research and collaboration in addressing complex medical challenges, underscoring the vital role inventors play in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile